At a glance
ClinicalIndex Comparison RecordN/ACompleted· 201 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Antimanic Drug Use in Pregnancy
In Brief
An observational study for Bipolar Disorder and Pregnancy. Completed, enrolled 201 participants across 1 site.
Detailed Summary
The purpose of this study is to learn about the effects of bipolar disorder or the use of antimanic medications on the mother's health and wellbeing during pregnancy and for the first postpartum year. Infant health and development are also assessed during the first year. Participation in the study includes 7 study visits, three in pregnancy and four postpartum.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder, Pregnancy
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2006
First PostedJan 2008
Primary CompletionMar 2012
TodayJul 2026
First PostedJan 3, 2008
Enrollment StartAug 1, 2006
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 18.5 years ago